Company Overview and News
TORONTO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. II ("Dividend 15 II") declares its regular monthly distribution of $0.10000 for each Class A share and $0.04375 for each Preferred share. The net asset value at the time of declaration was $15.10. Distributions are payable September 10, 2018 to shareholders on record as at August 31, 2018.
SLF TAC CIFAF TD BCE TD TRP TNTTF DF SLF MFC 0945 CIX TRI MFC SLFYF TU SLF
TORONTO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annually) and $0.04583 for each Preferred share ($0.550 annually). Distributions are payable September 10, 2018 to shareholders on record as at August 31, 2018.
CIFAF GLSSP GWO JBK TFG MFC 0945 CGBBW CIX SLFYF GWLIF SLF WFCNP SLF TD GS TD WFC TNTTF C GSC GSJ SLF GWLOF MFC GJS
TORONTO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- M Split Corp. ("M Split") declares its monthly distribution of $0.03125 per share ($0.375 annually) for Class I Preferred shareholders. The Class I Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price. Distributions are payable September 10, 2018 to shareholders on record as at August 31, 2018.
MFC 0945 MFC
TORONTO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. declares its 173rd consecutive monthly distribution of $0.10000 for each Class A share ($1.20 annually) and $0.04375 for each Preferred share ($0.525 annually). Distributions are payable September 10, 2018 to shareholders on record as at August 31, 2018.
SLF TAC CIFAF TD BCE TD TRP TNTTF SLF MFC 0945 CIX TRI MFC SLFYF TU SLF
TORONTO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Canadian Life Companies Split Corp. (The "Company") declares its monthly distribution of $0.05208 for each Preferred share ($0.625 annually). Distributions are payable September 10, 2018 to shareholders on record as at August 31, 2018.
SLF SLF MFC 0945 MFC SLFYF SLF
(Reuters) - Canada’s main stock index slipped on Friday after a much stronger-than-expected inflation data bolstered expectations of an interest rate hike as early as next month.
ACBFF NGDAF CG NGD CAGDF APH BAM ABX WPM BAMGF NGD ABX LYDIF MFC ACB 0945 MFC APHQF BAMKF
2018-08-14 reuters - 1
(Reuters) - Canada’s main stock index climbed on Tuesday as higher oil prices lifted energy stocks and concerns around Turkey’s currency crisis receded.
ACBFF HRNNF TD SU TWMJF WEED TD EGO SU HCG H TNTTF HMCBF CGC MFC ACB 0945 ELD CNQ MFC
TORONTO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Big 8 Split Inc. (TSX:BIG.D) (TSX:BIG.pr.D) (the “Company”) announced today that it has declared a quarterly dividend of $0.1125 per Class D Preferred Share. In addition, a quarterly dividend on its Class D Capital Shares was declared of $0.043 per Class D Capital Share. The dividends on both the Class D Preferred Shares and Class D Capital Shares are payable on September 14, 2018 to holders of record on August 31, 2018.
SLF TD GWO TD TNTTF SLF MFC 0945 GWLOF MFC SLFYF GWLIF SLF
Manulife Financial Corporation (MFC - Free Report) delivered second-quarter 2018 core earnings of $1.11 billion (C$1,431 million), up 23.3% year over year. This upside stemmed from double-digit core earnings growth across all operating segments as well as solid net income.
FISI GD ZTO PGR FIISO FIISP MTG MFC 0945 MFC RLI
Aug 9 (Reuters) - Canada’s main stock index rose on Thursday, as energy shares bounced back on higher oil prices and Saudi Arabia reassured Canada on oil supplies following an ongoing diplomatic dispute.
PXT CDNTF PARXF TREVF MFC HZM 0945 HZM CDNAF MFC
TORONTO (Reuters) - Canada’s biggest insurer Manulife Financial Corp (MFC.TO) on Wednesday reported second-quarter earnings which were ahead of market forecasts, driven by a strong performance across all its businesses.
MFC 0945 MFC
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...